Hansa Biopharma secures €115 million licensing deal with SERB
Statements (2)
- Neutral
Hansa Biopharma closed a €115 million licensing transaction with SERB Cash
- Neutral
Hansa Biopharma closed a €115 million licensing transaction with SERB
Hansa Biopharma closed a €115 million licensing transaction with SERB Cash
Hansa Biopharma closed a €115 million licensing transaction with SERB